Five-Year Outcomes of the SuperB Trial: A Multicenter Randomized Controlled Trial Comparing Heparin-Bonded Endograft to Surgical Femoropopliteal Bypass.
Laurens A van WalravenIris P S van WijckMichel M P J ReijnenWilbert M FritschyClark J ZeebregtsSuzanna M LemsonOtmar R M WikkelingMichel M P J ReijnenPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2024)
This present study is the first to report five-year outcomes comparing an endoluminal (EB) using heparin-bonded self-expanding covered stents with surgical bypass (SB) for long and complex femoropopliteal disease. Although the advantages of treatment with EB are mostly seen in the early period after treatment, the outcomes support the use of EB for this indication and seems to be a valid and safe alternative for bypass surgery. Future trials comparing various endovascular strategies may provide further guidance for the development of an evidence-based treatment algorithm.
Keyphrases
- randomized controlled trial
- study protocol
- venous thromboembolism
- minimally invasive
- clinical trial
- machine learning
- systematic review
- metabolic syndrome
- deep learning
- growth factor
- type diabetes
- adipose tissue
- coronary artery bypass
- combination therapy
- weight loss
- insulin resistance
- abdominal aortic
- smoking cessation
- meta analyses